Texas Permanent School Fund Corp Sells 1,884 Shares of Envista Holdings Co. (NYSE:NVST)

Texas Permanent School Fund Corp reduced its stake in shares of Envista Holdings Co. (NYSE:NVST) by 1.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 149,889 shares of the company’s stock after selling 1,884 shares during the quarter. Texas Permanent School Fund Corp owned 0.09% of Envista worth $3,205,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Fifth Third Bancorp raised its position in Envista by 98.1% in the 4th quarter. Fifth Third Bancorp now owns 1,254 shares of the company’s stock worth $30,000 after purchasing an additional 621 shares during the last quarter. Signaturefd LLC increased its stake in shares of Envista by 1,297.9% in the 4th quarter. Signaturefd LLC now owns 2,614 shares of the company’s stock valued at $63,000 after buying an additional 2,427 shares during the period. Quadrant Capital Group LLC raised its position in shares of Envista by 538.0% during the fourth quarter. Quadrant Capital Group LLC now owns 3,209 shares of the company’s stock worth $77,000 after acquiring an additional 2,706 shares during the last quarter. Van ECK Associates Corp lifted its stake in shares of Envista by 15.4% during the fourth quarter. Van ECK Associates Corp now owns 5,646 shares of the company’s stock valued at $136,000 after acquiring an additional 755 shares during the period. Finally, Johnson Financial Group Inc. bought a new position in Envista in the fourth quarter valued at about $136,000.

Envista Stock Down 4.2 %

NVST stock opened at $16.04 on Monday. The company has a fifty day moving average price of $17.74 and a two-hundred day moving average price of $20.50. Envista Holdings Co. has a one year low of $15.69 and a one year high of $36.14. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.34.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, May 1st. The company reported $0.26 earnings per share for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.05). Envista had a positive return on equity of 5.84% and a negative net margin of 4.70%. The firm had revenue of $623.60 million for the quarter, compared to analyst estimates of $634.85 million. During the same period in the prior year, the business posted $0.38 EPS. The firm’s quarterly revenue was down .6% compared to the same quarter last year. Equities analysts anticipate that Envista Holdings Co. will post 1.2 earnings per share for the current year.

Wall Street Analysts Forecast Growth

NVST has been the topic of several analyst reports. Evercore ISI lowered their price target on Envista from $24.00 to $19.00 and set an “outperform” rating for the company in a research note on Tuesday, June 25th. The Goldman Sachs Group cut their target price on shares of Envista from $20.00 to $17.50 and set a “sell” rating on the stock in a report on Friday, May 3rd. Morgan Stanley cut shares of Envista from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $33.00 to $21.00 in a research report on Friday, April 26th. Robert W. Baird dropped their price objective on Envista from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Thursday, May 2nd. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Envista in a report on Monday, June 3rd. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $22.85.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.